All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

72

Reset

72 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • CGB-500Phase 22 trials

    CAGE Bio Inc. · Atopic Dermatitis (AD)

  • FB825Phase 22 trials

    Oneness Biotech Co., Ltd. · Allergic Asthma, Atopic Dermatitis

  • JNJ-95597528Phase 22 trials

    Johnson & Johnson (Janssen) · Dermatitis, Atopic, Asthma

  • JYP0061Experimental Drug GroupPhase 22 trials

    Guangzhou JOYO Pharma Co., Ltd · Moderate-to-severe Atopic Dermatitis, Neuromyelitis Optica Spectrum Disorders

  • ModzatinibATI-2138Phase 22 trials

    Aclaris Therapeutics, Inc. · Lichen Planus, Atopic Dermatitis

  • XKH001InjectionXKH001Phase 22 trials

    Zhejiang Kanova Biopharmaceutical Co., LTD · COPD, Atopic Dermatitis

  • ATI-045Phase 21 trial

    Aclaris Therapeutics, Inc. · Atopic Dermatitis, Atopic, Dermatitis

  • EVO301Phase 21 trial

    Evommune, Inc. · Atopic Dermatitis (AD), Eczema, Eczema Atopic Dermatitis

  • GHZ339Phase 21 trial

    Novartis · Atopic Dermatitis

  • HL-300Phase 21 trial

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Atopic Dermatitis

  • HXN6005Phase 21 trial

    Helixon Biotechnology (Suzhou) Co., Ltd · Health Adult Subjects, Atopic Dermatitis (AD)

  • IBI3002Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis

  • LEO 138559LEO 138559 is also called "temtokibart"Phase 21 trial

    LEO Pharma · Atopic Dermatitis

  • PF-07264660Phase 21 trial

    Pfizer · Atopic Dermatitis

  • PF-08049820Phase 21 trial

    Pfizer · Atopic Dermatitis, Eczema, Atopic

  • SIM0278Phase 21 trial

    Jiangsu Simcere Pharmaceutical Co., Ltd. · Atopic Dermatitis (AD)

  • STMC-103HPhase 21 trial

    Siolta Therapeutics, Inc. · Atopic Dermatitis, Type 1 Hypersensitivity

  • TAVO101Phase 21 trial

    Tavotek Biotherapeutics · Atopic Dermatitis

  • TRIV-509Phase 21 trial

    Triveni Bio · Atopic Dermatitis

  • TRIV-573Phase 21 trial

    Triveni Bio · Atopic Dermatitis

  • UCB1381Phase 21 trial

    UCB · Atopic Dermatitis

  • YR001Phase 21 trial

    Hangzhou Yirui Pharmaceutical Technology Co., Ltd · Atopic Dermatitis

NewerPage 2 of 2

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.